Back to Journals » OncoTargets and Therapy » Volume 9

Review

Lenvatinib and other tyrosine kinase inhibitors for the treatment of radioiodine refractory, advanced, and progressive thyroid cancer

       
Total article views   HTML views PDF downloads Totals
15,569 Dovepress* 10,671+ 1,598 12,269
PubMed Central* 4,898 1,111 6,009
Totals 15,569 2,709 18,278
*Since 20 October 2016

View citations on PubMed and Google Scholar